Cargando…
Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study
OBJECTIVE: Several studies have provided insights into the conditions for successful patient involvement in health research. We recently demonstrated that long-term engagement with people with rheumatic conditions in international outcome research led to significant changes in the research agenda in...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753501/ https://www.ncbi.nlm.nih.gov/pubmed/23975104 http://dx.doi.org/10.1136/bmjopen-2013-003311 |
_version_ | 1782281842862325760 |
---|---|
author | de Wit, Maarten Abma, Tineke Koelewijn-Van Loon, Marije Collins, Sarah Kirwan, John |
author_facet | de Wit, Maarten Abma, Tineke Koelewijn-Van Loon, Marije Collins, Sarah Kirwan, John |
author_sort | de Wit, Maarten |
collection | PubMed |
description | OBJECTIVE: Several studies have provided insights into the conditions for successful patient involvement in health research. We recently demonstrated that long-term engagement with people with rheumatic conditions in international outcome research led to significant changes in the research agenda in the field of rheumatology. This article explores facilitating and inhibiting factors for long-term involvement of patients as collaborative partners at five Outcome Measures in Rheumatology (OMERACT) conferences. DESIGN: Responsive evaluation, starting with a thematic document analysis of conference proceedings and the grey literature, followed by 38 qualitative interviews. Interview transcripts were subjected to inductive content analysis. SETTING: 5 international OMERACT conferences between 2002 and 2012. PARTICIPANTS: Patient delegates (n=16) and professional delegates representing researchers (n=14), pharmaceutical industry and regulators (n=2). RESULTS: Combined review of the document analysis and interview data revealed five main facilitators and three main barriers. Patient engagement as full participants at OMERACT conferences was enhanced by: strong leadership commitment and the presence of change agents, a clear selection procedure, an inclusive consensus-based conference design, individualised and self-organised support, an interactive and encouraging moderation style during discussion groups. Barriers were related to the intensity of the conference programme, scepticism among researchers and doubts about the representativeness of the patient group. CONCLUSIONS: This study concludes that developing a sustainable structure for funding, selection and support of patient delegates, as well as adjusting conference design and moderation style, contributes not only towards facilitating direct dialogue between all stakeholders but also towards enhancing mutual understanding and the successful incorporation of the patient perspective in an outcome conference such as OMERACT. |
format | Online Article Text |
id | pubmed-3753501 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-37535012013-08-28 Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study de Wit, Maarten Abma, Tineke Koelewijn-Van Loon, Marije Collins, Sarah Kirwan, John BMJ Open Rheumatology OBJECTIVE: Several studies have provided insights into the conditions for successful patient involvement in health research. We recently demonstrated that long-term engagement with people with rheumatic conditions in international outcome research led to significant changes in the research agenda in the field of rheumatology. This article explores facilitating and inhibiting factors for long-term involvement of patients as collaborative partners at five Outcome Measures in Rheumatology (OMERACT) conferences. DESIGN: Responsive evaluation, starting with a thematic document analysis of conference proceedings and the grey literature, followed by 38 qualitative interviews. Interview transcripts were subjected to inductive content analysis. SETTING: 5 international OMERACT conferences between 2002 and 2012. PARTICIPANTS: Patient delegates (n=16) and professional delegates representing researchers (n=14), pharmaceutical industry and regulators (n=2). RESULTS: Combined review of the document analysis and interview data revealed five main facilitators and three main barriers. Patient engagement as full participants at OMERACT conferences was enhanced by: strong leadership commitment and the presence of change agents, a clear selection procedure, an inclusive consensus-based conference design, individualised and self-organised support, an interactive and encouraging moderation style during discussion groups. Barriers were related to the intensity of the conference programme, scepticism among researchers and doubts about the representativeness of the patient group. CONCLUSIONS: This study concludes that developing a sustainable structure for funding, selection and support of patient delegates, as well as adjusting conference design and moderation style, contributes not only towards facilitating direct dialogue between all stakeholders but also towards enhancing mutual understanding and the successful incorporation of the patient perspective in an outcome conference such as OMERACT. BMJ Publishing Group 2013-08-22 /pmc/articles/PMC3753501/ /pubmed/23975104 http://dx.doi.org/10.1136/bmjopen-2013-003311 Text en Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 3.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/3.0/ |
spellingShingle | Rheumatology de Wit, Maarten Abma, Tineke Koelewijn-Van Loon, Marije Collins, Sarah Kirwan, John Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title | Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title_full | Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title_fullStr | Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title_full_unstemmed | Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title_short | Facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in OMERACT: a qualitative study |
title_sort | facilitating and inhibiting factors for long-term involvement of patients at outcome conferences—lessons learnt from a decade of collaboration in omeract: a qualitative study |
topic | Rheumatology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753501/ https://www.ncbi.nlm.nih.gov/pubmed/23975104 http://dx.doi.org/10.1136/bmjopen-2013-003311 |
work_keys_str_mv | AT dewitmaarten facilitatingandinhibitingfactorsforlongterminvolvementofpatientsatoutcomeconferenceslessonslearntfromadecadeofcollaborationinomeractaqualitativestudy AT abmatineke facilitatingandinhibitingfactorsforlongterminvolvementofpatientsatoutcomeconferenceslessonslearntfromadecadeofcollaborationinomeractaqualitativestudy AT koelewijnvanloonmarije facilitatingandinhibitingfactorsforlongterminvolvementofpatientsatoutcomeconferenceslessonslearntfromadecadeofcollaborationinomeractaqualitativestudy AT collinssarah facilitatingandinhibitingfactorsforlongterminvolvementofpatientsatoutcomeconferenceslessonslearntfromadecadeofcollaborationinomeractaqualitativestudy AT kirwanjohn facilitatingandinhibitingfactorsforlongterminvolvementofpatientsatoutcomeconferenceslessonslearntfromadecadeofcollaborationinomeractaqualitativestudy |